Skip to content

Tumor Rejection and Prevention of Tumor’s Reoccurrence by T cells with Dual Anti-virus/Anti-tumor Specificity

A novel immunotherapy approach combining vaccine and adoptive cellular therapy overcoming resistant tumor microenvironment

Published: 8th October 2021
Tumor Rejection and Prevention of Tumor’s Reoccurrence by T cells with Dual Anti-virus/Anti-tumor Specificity
Christoph Burgstedt, https://stock.adobe.com/uk/243124795, stock.adobe.com
Seeking
  • Development partner
  • Commercial partner
  • Licensing
  • Seeking investment